EUVIMEDEUVIMED entdecken
Crossref

Concurrent administration of farnesol protects acetaminophen‐induced acute hepatic necrosis in mice

Ramalingam Gayatri Devi, Devaraj Ezhilarasan

Journal of Biochemical and Molecular Toxicology · 2023

DOI: 10.1002/jbt.23478 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2023. Verfasst von Ramalingam Gayatri Devi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India. Hauptthemen laut MEDLINE: Acetaminophen, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acetaminophen (APAP) is known to cause acute liver injury and acute liver failure in Western countries. This study investigates the protective role of farnesol (FAR) (C 15 H 26 O), a natural sesquiterpene alcohol in essential oils, against APAP‐induced acute liver necrosis in mice. Mice were injected with a single dose of APAP (300 mg/kg) via an intraperitoneal route. Different groups of mice were concurrently treated with a single dose of FAR 25 mg/kg, FAR 50 mg/kg, and N ‐acetylcysteine. APAP administration caused a significant increase in transaminase activities and malondialdehyde (MDA) levels in the serum and liver tissue, respectively, with a concomitant decrease in intracellular antioxidants, including reduced glutathione (GSH) in the liver tissue. APAP intoxication upregulated proinflammatory cytokines such as tumor necrosis factor‐α, interleukin‐1β (IL‐1β), IL‐6, nuclear factor‐κB (NF‐κB), and IκB kinase β in the liver tissue. FAR and N ‐acetylcysteine (NAC) administrations concurrently with APAP prevented serum transaminase increase in serum and MDA levels in the liver tissue. A high dose of FAR and NAC treatments significantly inhibited GSH and other antioxidant depletion. FAR and NAC treatments also downregulated the expression of proinflammatory markers. FAR treatments protects against APAP‐induced acute liver injury and offers antioxidant and anti‐inflammatory effects by inhibiting the NF‐κB pathway involved in the transcription of genes responsible for inflammatory cytokine synthesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetaminophenChemical and Drug Induced Liver InjuryMiceAnimalsAntioxidantsFarnesolNF-kappa BAcetylcysteineLiverGlutathioneNecrosisTransaminasesAlanine Transaminase

Stichwörter der Autor:innen

acetaminophenfarnesolglutathionehepatic necrosis

Substanzen

AcetaminophenAntioxidantsFarnesolNF-kappa BAcetylcysteineGlutathioneTransaminasesAlanine Transaminase

Autor:innen und Institutionen

  • Department of Physiology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India.
  • Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai, Tamil Nadu, India.

Zitieren

APA

Gayatri Devi, R., & Ezhilarasan, D. (2023). Concurrent administration of farnesol protects acetaminophen‐induced acute hepatic necrosis in mice. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23478

Vancouver

Gayatri Devi R, Ezhilarasan D. Concurrent administration of farnesol protects acetaminophen‐induced acute hepatic necrosis in mice. Journal of Biochemical and Molecular Toxicology. 2023. doi:10.1002/jbt.23478

BibTeX
@article{GayatriDevi2023,
  author = {Gayatri Devi, Ramalingam and Ezhilarasan, Devaraj},
  title = {Concurrent administration of farnesol protects acetaminophen‐induced acute hepatic necrosis in mice},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2023},
  doi = {10.1002/jbt.23478}
}
Kostenlos starten →